Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
B.1.1.153NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15023.7China
B.1.1.370NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15034.8China
B.1.1.95NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15034.8China
JD.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
XBB.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
BE.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
XBB.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
B.1.1.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
XBB.1.5.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
KP.4.1.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15045.7Hong Kong
XBB.8.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
XBB.1.41.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
JN.1.65NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
JN.1.65.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
MF.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
MF.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
B.1.1.367NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
B.1.1.429NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
B.1.1.236NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
HK.3.5NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-15046.9Hong Kong
B.1.112EHuang-EGCAGCAGTACGCACACAATC20552637626357R-15066.9China
B.1.318SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-15084.2Japan
JN.5SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-15084.9Japan
FL.31ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-15087.3Germany
FL.31.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-15087.3Germany
N.8ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-15087.9France
DV.7.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-15090.2South Korea
BA.2.9ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15093.4France
BA.2.24SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-15095.1Japan
BF.7.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
B.1.581ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
B.1.252ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
BA.5.1.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
JN.1.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
EG.5.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
A.23.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
B.1.1.306ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-15158.8Hong Kong
B.1.518ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
B.1.480ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
B.1.1.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
BA.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
CJ.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
FL.26.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
DJ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
JN.1.8.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
AY.9.2.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used